| Symbol | DNTH |
|---|---|
| Name | DIANTHUS THERAPEUTICS, INC. /DE/ |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | Pharmaceutical Preparations |
| Address | 7 TIMES SQUARE, NEW YORK, NY 10036 |
| Telephone | 929-999-4055 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001690585 |
| Description | None |
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q2 2026 Financial Results
Read moreDianthus Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)
Read moreDianthus Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(C)(4)
Read moreDianthus Therapeutics Announces Initiation of Phase 3 Emerge Trial of Claseprubart in Generalized Myasthenia Gravis
Read more📋 ADAM M VENESS (Officer) plans to sell 30K shares of DIANTHUS THERAPEUTICS INC (at $78.88 each, total $2.4M) Filed: Jun 17, 2026 | ID: 006275
Read moreRandhawa Simrat 🟡 adjusted position in 26.5K shares (4 derivative) of Dianthus Therapeutics, Inc. /DE/ (DNTH) at $91.37 ($3.4M) Transaction Date: Jun 01, 2026 | Filing ID: 000006
Read moreDianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Read more📋 SIMRAT RANDHAWA (Officer) plans to sell 27K shares of DIANTHUS THERAPEUTICS INC (at $93.01 each, total $2.5M) Filed: Jun 01, 2026 | ID: 005356
Read moreRomano Steven J. 🟢 acquired 6.1K shares (1 derivative) of Dianthus Therapeutics, Inc. /DE/ (DNTH) at $89.63 Transaction Date: May 21, 2026 | Filing ID: 000005
Read more